• 1
    Cohen M 2000 Craniosynostosis. In: CohenM (ed.) Craniosynostosis Diagnosis Evaluation and Management, 2nd ed. Oxford, New York, NY, USA, P 112117.
  • 2
    Jabs EW, Muller U, Li X, Ma L, Luo W, Haworth IS, Klisak I, Sparkes R, Warman ML, Mulliken JB, Snead ML, Maxson R 1993 A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis. Cell 75:443450.
  • 3
    Liu YH, Tang Z, Kundu RK, Wu L, Luo W, Zhu D, Sangiorgi F, Snead ML, Maxson RE 1999 Msx2 gene dosage influences the number of proliferative osteogenic cells in growth centers of the developing murine skull: A possible mechanism for MSX2-mediated craniosynostosis in humans. Dev Biol 205:260274.
  • 4
    Furtwangler JA, Hall SH, Koskinen-Moffett LK 1985 Sutural morphogenesis in the mouse calvaria: The role of apoptosis. Acta Anat (Basel) 124:7480.
  • 5
    Mansukhani A, Bellosta P, Sahni M, Basilico C 2000 Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts. J Cell Biol 149:12971308.
  • 6
    Rice DP, Kim HJ, Thesleff I 1999 Apoptosis in murine calvarial bone and suture development. Eur J Oral Sci 107:265275.
  • 7
    Opperman LA, Adab K, Gakunga PT 2000 Transforming growth factor-beta 2 and TGF-beta 3 regulate fetal rat cranial suture morphogenesis by regulating rates of cell proliferation and apoptosis. Dev Dyn 219:237247.
  • 8
    Lemonnier J, Haÿ E, Delannoy P, Fromigué O, Lomri A, Modrowski D, Marie PJ 2001 Increased osteoblast apoptosis in apert craniosynostosis: Role of protein kinase C and interleukin-1. Am J Pathol 158:18331842.
  • 9
    Yousfi M, Lasmoles F, Lomri A, Delannoy P, Marie PJ 2001 Increased bone formation and decreased osteocalcin expression induced by reduced Twist dosage in Saethre-Chotzen syndrome. J Clin Invest 107:11531161.
  • 10
    Watanabe TK, Katagiri T, Suzuki M, Shimizu F, Fujiwara T, Kanemoto N, Nakamura Y, Hirai Y, Maekawa H, Takahashi E 1996 Cloning and characterization of two novel human cDNAs (NELL1 and NELL2) encoding proteins with six EGF-like repeats. Genomics 38:273276.
  • 11
    Ting K, Vastardis H, Mulliken JB, Soo C, Tieu A, Do H, Kwong E, Bertolami CN, Kawamoto H, Kuroda S, Longaker MT 1999 Human NELL-1 expressed in unilateral coronal synostosis. J Bone Miner Res 14:8089.
  • 12
    Kuroda S, Oyasu M, Kawakami M, Kanayama N, Tanizawa K, Saito N, Abe T, Matsuhashi S, Ting K 1999 Biochemical characterization and expression analysis of neural thrombospondin-1-like proteins NELL1 and NELL2. Biochem Biophys Res Commun 265:7986.
  • 13
    Kuroda S, Tanizawa K 1999 Involvement of epidermal growth factor-like domain of NELL proteins in the novel protein-protein interaction with protein kinase C. Biochem Biophys Res Commun 265:752757.
  • 14
    Bornstein P 1995 Diversity of function is inherent in matricellular proteins: An appraisal of thrombospondin 1. J Cell Biol 130:503506.
  • 15
    Zhang X, Kuroda S, Carpenter D, Nishimura I, Soo C, Moats R, Iida K, Wisner E, Hu FY, Miao S, Beanes S, Dang C, Vastardis H, Longaker M, Tanizawa K, Kanayama N, Saito N, Ting K 2002 Craniosynostosis in transgenic mice overexpressing Nell-1. J Clin Invest 110:861870.
  • 16
    Ting K, Petropulos LA, Iwatsuki M, Nishimura I 1993 Altered cartilage phenotype expressed during intramembranous bone formation. J Bone Miner Res 8:13771387.
  • 17
    Simpson JF, Dutt PL, Page DL 1992 Expression of mitoses per thousand cells and cell density in breast carcinomas: A proposal. Hum Pathol 23:608611.
  • 18
    Sayah DN, Soo C, Shaw WW, Watson J, Messadi D, Longaker MT, Zhang X, Ting K 1999 Downregulation of apoptosis-related genes in keloid tissues. J Surg Res 87:209216.
  • 19
    Lomri A, Marie PJ 1990 Bone cell responsiveness to transforming growth factor beta, parathyroid hormone, and prostaglandin E2 in normal and postmenopausal osteoporotic women. J Bone Miner Res 5:11491155.
  • 20
    Fromigue O, Marie PJ, Lomri A 1998 Bone morphogenetic protein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromal cell proliferation and differentiation. J Cell Biochem 68:411426.
  • 21
    Kawakami A, Eguchi K, Matsuoka N, Tsuboi M, Koji T, Urayama S, Fujiyama K, Kiriyama T, Nakashima T, Nakane PK, Nagataki S 1997 Fas and Fas ligand interaction is necessary for human osteoblast apoptosis. J Bone Miner Res 12:16371646.
  • 22
    Price BD, Calderwood SK 1992 Gadd45 and Gadd153 messenger RNA levels are increased during hypoxia and after exposure of cells to agents which elevate the levels of the glucose-regulated proteins. Cancer Res 52:38143817.
  • 23
    Tsuboi M, Kawakami A, Nakashima T, Matsuoka N, Urayama S, Kawabe Y, Fujiyama K, Kiriyama T, Aoyagi T, Maeda K, Eguchi K 1999 Tumor necrosis factor-alpha and interleukin-1beta increase the Fas-mediated apoptosis of human osteoblasts. J Lab Clin Med 134:222231.
  • 24
    Hay E, Lemonnier J, Fromigue O, Marie PJ 2001 Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway. J Biol Chem 276:2902829036.
  • 25
    Nasatzky E, Grinfeld D, Boyan BD, Dean DD, Ornoy A, Schwartz Z 1999 Transforming growth factor-beta1 modulates chondrocyte responsiveness to 17beta-estradiol. Endocrine 11:241249.
  • 26
    Opperman LA 2000 Cranial sutures as intramembranous bone growth sites. Dev Dyn 219:472485.
  • 27
    Marie P 2000 Significance of growth factors in bone repair. Growth factors and bone tissue. Rev Chir Orthop Reparatrice Appar Mot 86(Suppl 1):150151.
  • 28
    Lynch MP, Capparelli C, Stein JL, Stein GS, Lian JB 1998 Apoptosis during bone-like tissue development in vitro. J Cell Biochem 68:3149.
  • 29
    Garcia Abreu J, Coffinier C, Larrain J, Oelgeschlager M, De Robertis EM 2002 Chordin-like CR domains and the regulation of evolutionarily conserved extracellular signaling systems. Gene 287:3947.
  • 30
    Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SM, Lawler J, Hynes RO, Boivin GP, Bouck N 1998 Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 93:11591170.
  • 31
    Piccolo S, Agius E, Lu B, Goodman S, Dale L, De Robertis EM 1997 Cleavage of Chordin by Xolloid metalloprotease suggests a role for proteolytic processing in the regulation of Spemann organizer activity. Cell 91:407416.
  • 32
    Jilka RL, Weinstein RS, Bellido T, Roberson P, Parfitt AM, Manolagas SC 1999 Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest 104:439446.
  • 33
    Plotkin LI, Weinstein RS, Parfitt AM, Roberson PK, Manolagas SC, Bellido T 1999 Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest 104:13631374.